American Journal of Internal Medicine

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Isolated Thrombocytopenia as an Initial Presentation of Systemic Lupus Erythematosus: A Case Report of a 17 Year Old Female

Background: Childhood systemic lupus erythematosus (SLE) can manifest in various ways, with hematologic abnormalities being common. However, isolated thrombocytopenia is relatively infrequent. Case Presentation: In this case report, we describe a 17-year-old female patient who presented with complaints of generalized body aches, weakness, anorexia, and recent epistaxis, with no relevant medical history, medication use, smoking, or bleeding disorder in the family. After excluding infectious and other autoimmune causes, SLE was the final diagnosis due to high ANA and anti-dsDNA titers. Despite conventional steroid therapy, the patient's platelet count remained low, prompting the increase of prednisolone up to 2mg/kg/day. By day 7th, the platelet numbers reached to 85000/μl, indicating a favorable response. Conclusion: Our findings suggest that when isolated thrombocytopenia does not respond to conventional steroid therapy, SLE should be considered, and that a child presenting with isolated hematological abnormality should be screened for childhood-onset SLE.

Isolated Thrombocytopenia, 17 Years Old Female, Initial Presentation of SLE, ANA, Anti dsDNA, A Case Report

APA Style

Rizwanullah, Shehriyar, Khayam, Muhammad Saad, Aiysha Gul. (2023). Isolated Thrombocytopenia as an Initial Presentation of Systemic Lupus Erythematosus: A Case Report of a 17 Year Old Female. American Journal of Internal Medicine, 11(3), 60-63. https://doi.org/10.11648/j.ajim.20231103.16

ACS Style

Rizwanullah; Shehriyar; Khayam; Muhammad Saad; Aiysha Gul. Isolated Thrombocytopenia as an Initial Presentation of Systemic Lupus Erythematosus: A Case Report of a 17 Year Old Female. Am. J. Intern. Med. 2023, 11(3), 60-63. doi: 10.11648/j.ajim.20231103.16

AMA Style

Rizwanullah, Shehriyar, Khayam, Muhammad Saad, Aiysha Gul. Isolated Thrombocytopenia as an Initial Presentation of Systemic Lupus Erythematosus: A Case Report of a 17 Year Old Female. Am J Intern Med. 2023;11(3):60-63. doi: 10.11648/j.ajim.20231103.16

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58: 556-62.
2. Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, et al. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol. 2010; 149 (6): 855-64. https://doi.org/10.1111/j.1365-2141.2010.08176.x PMid: 20377590
3. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-6.
4. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
5. Sandoval C, Visintainer P, Ozkaynak MF, Tugal O, Jayabose S. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura. Pediatr Blood Cancer. 2004; 42 (1): 109-12. https://doi.org/10.1002/pbc.10458, PMid: 14752803.
6. Jung JY, Rum OA, MD, Kim JK, Park M. Clinical course and prognostic factors of childhood immune thrombocytopenia: Single center experience of 10 years. Korean J Pediatr.
7. Audia S, Mahevas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017; 16 (6): 620-32. https://doi.org/10.1016/j.autrev.2017.04.012, PMid: 28428120.
8. Hakim AJ, Machin SJ, Isenberg DA. Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: The response to splenectomy. Semin Arthritis Rheum. 1998; 28 (1): 20-5. https://doi.org/10.1016/ s0049-0172 (98) 80024-3, PMid: 9726332.
9. Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: Significant in the clinical implication and prognosis. Platelets. 2010; 21 (5): 380-5. https://doi.org/10.3109/09537101003735564, PMid: 20433308.
10. Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer. 2006; 47 (5): 657-9. https://doi.org/10.1002/ pbc.20970, PMid: 16933242.
11. Altintas A, Ozel A, Okur N, Okur N, Cil T, Pasa S, Ayyildiz O. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis. 2007 Oct; 24 (2): 163-8. doi: 10.1007/s11239-007-0031-y. Epub 2007 Apr 14. PMID: 17436144.
12. Campos LM, Spadoni MS, Michelin CM, Jesus AA, Carneiro JD, da Silva CA. Thrombotic thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients. Rev Bras Reumatol. 2013 Feb; 53 (1): 120-6. English, Portuguese. PMID: 23588522.
13. Vimal Master Sankar Raj, "An Unusual Presentation of Lupus in a Pediatric Patient", Case Reports in Pediatrics, vol. 2013, Article ID 180208, 4 pages, 2013. https://doi.org/10.1155/2013/180208
14. Dou X, Yang R. Current and emerging treatments for immune thrombocytopenia, Expert Rev Hematol. 2019; 12 (9): 723-32. https://doi.org/10.1080/17474086.2019.1636644, PMid: 31237783.
15. Audia S, Bonnotte B. Emerging Therapies in Immune Thrombocytopenia. J Clin Med. 2021 Mar 2; 10 (5): 1004. doi: 10.3390/jcm10051004. PMID: 33801294; PMCID: PMC7958340.